• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下调长链非编码 RNA HOTAIR 通过微小 RNA-130a 减少胰岛素样生长因子 1 的表达,从而减轻大鼠多囊卵巢综合征。

Down-regulated lncRNA HOTAIR alleviates polycystic ovaries syndrome in rats by reducing expression of insulin-like growth factor 1 via microRNA-130a.

机构信息

Department of Gynaecology, The Third Xiangya Hospital of Central South University, Changsha, China.

出版信息

J Cell Mol Med. 2020 Jan;24(1):451-464. doi: 10.1111/jcmm.14753. Epub 2019 Nov 16.

DOI:10.1111/jcmm.14753
PMID:31733099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6933321/
Abstract

It has been found that long noncoding RNA HOTAIR, microRNA-130a (miR-130a) and insulin-like growth factor 1 (IGF1) expression are associated with ovarian cancer, thus, we hypothesised that the HOTAIR/miR-130a/IGF1 axis might associate with endocrine disorders and biological behaviours of ovarian granulosa cells in rat models of polycystic ovary syndrome (PCOS). PCOS rat models were established by injection of dehydro-isoandrosterone, followed by treatment of si-HOTAIR, oe-HOTAIR, miR-130a mimics or miR-130a inhibitors. Serum hormonal levels were determined to evaluate endocrine conditions. The effect of HOTAIR and miR-130a on activities of isolated ovarian granulosa cells was assessed, as well as the involvement of IGF1.In the ovarian tissues and granulosa cells of PCOS rat models, highly expressed HOTAIR and IGF1 and poorly expressed miR-130a were identified. In response to oe-HOTAIR, serum levels of E , T and LH were increased and serum levels of FSH were reduced; the proliferation of granulosa cells was reduced and apoptosis was promoted; notably, expression of miR-130a was reduced while expression of IGF1 was increased. The treatment of si-HOTAIR reversed the situation. Furthermore, the binding of HOTAIR to miR-130a and targeting relationship of miR-130a and IGF1 were confirmed. LncRNA HOTAIR up-regulates the expression of IGF1 and aggravates the endocrine disorders and granulosa cell apoptosis through competitive binding to miR-130a in rat models of PCOS. Based on our finding, we predict that competitive binding of HOTAIR to miR-130a may act as a novel target for the molecular treatment of PCOS.

摘要

现已发现长链非编码 RNA HOTAIR、微小 RNA-130a(miR-130a)和胰岛素样生长因子 1(IGF1)的表达与卵巢癌有关,因此,我们假设 HOTAIR/miR-130a/IGF1 轴可能与多囊卵巢综合征(PCOS)大鼠模型中的卵巢颗粒细胞内分泌紊乱和生物学行为有关。通过注射脱氢异雄酮建立 PCOS 大鼠模型,然后用 si-HOTAIR、oe-HOTAIR、miR-130a 模拟物或 miR-130a 抑制剂进行处理。测定血清激素水平以评估内分泌状况。评估 HOTAIR 和 miR-130a 对分离的卵巢颗粒细胞活性的影响,以及 IGF1 的参与。在 PCOS 大鼠模型的卵巢组织和颗粒细胞中,发现 HOTAIR 和 IGF1 高表达,miR-130a 低表达。oe-HOTAIR 作用后,E、T 和 LH 血清水平升高,FSH 血清水平降低;颗粒细胞增殖减少,凋亡增加;miR-130a 表达减少,IGF1 表达增加。si-HOTAIR 的处理逆转了这种情况。此外,还证实了 HOTAIR 与 miR-130a 的结合以及 miR-130a 与 IGF1 的靶向关系。LncRNA HOTAIR 通过与 miR-130a 竞争结合,上调 IGF1 的表达,加重 PCOS 大鼠模型的内分泌紊乱和颗粒细胞凋亡。基于我们的发现,我们预测 HOTAIR 与 miR-130a 的竞争结合可能成为 PCOS 分子治疗的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/60bd4778b250/JCMM-24-451-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/0b4cf7ec36b9/JCMM-24-451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/1e43a4f28075/JCMM-24-451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/9e762928d8d8/JCMM-24-451-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/e1960e975677/JCMM-24-451-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/0ca58cae55df/JCMM-24-451-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/5e03e59a4970/JCMM-24-451-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/b77c3ad3f858/JCMM-24-451-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/60bd4778b250/JCMM-24-451-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/0b4cf7ec36b9/JCMM-24-451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/1e43a4f28075/JCMM-24-451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/9e762928d8d8/JCMM-24-451-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/e1960e975677/JCMM-24-451-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/0ca58cae55df/JCMM-24-451-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/5e03e59a4970/JCMM-24-451-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/b77c3ad3f858/JCMM-24-451-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1c/6933321/60bd4778b250/JCMM-24-451-g008.jpg

相似文献

1
Down-regulated lncRNA HOTAIR alleviates polycystic ovaries syndrome in rats by reducing expression of insulin-like growth factor 1 via microRNA-130a.下调长链非编码 RNA HOTAIR 通过微小 RNA-130a 减少胰岛素样生长因子 1 的表达,从而减轻大鼠多囊卵巢综合征。
J Cell Mol Med. 2020 Jan;24(1):451-464. doi: 10.1111/jcmm.14753. Epub 2019 Nov 16.
2
Downregulating lncRNA NEAT1 induces proliferation and represses apoptosis of ovarian granulosa cells in polycystic ovary syndrome via microRNA-381/IGF1 axis.下调 lncRNA NEAT1 通过 microRNA-381/IGF1 轴诱导多囊卵巢综合征卵巢颗粒细胞增殖并抑制其凋亡。
J Biomed Sci. 2021 Jul 15;28(1):53. doi: 10.1186/s12929-021-00749-z.
3
Down-regulation of MALAT1 aggravates polycystic ovary syndrome by regulating MiR-302d-3p-mediated leukemia inhibitory factor activity.MALAT1的下调通过调节MiR-302d-3p介导的白血病抑制因子活性加重多囊卵巢综合征。
Life Sci. 2021 Jul 15;277:119076. doi: 10.1016/j.lfs.2021.119076. Epub 2021 Jan 16.
4
Downregulation of lncRNA ZFAS1 and upregulation of microRNA-129 repress endocrine disturbance, increase proliferation and inhibit apoptosis of ovarian granulosa cells in polycystic ovarian syndrome by downregulating HMGB1.lncRNA ZFAS1的下调和微小RNA-129的上调通过下调高迁移率族蛋白B1(HMGB1)来抑制多囊卵巢综合征中内分泌紊乱,增加卵巢颗粒细胞增殖并抑制其凋亡。
Genomics. 2020 Sep;112(5):3597-3608. doi: 10.1016/j.ygeno.2020.04.011. Epub 2020 Apr 19.
5
Downregulated lncRNA HOTAIR ameliorates polycystic ovaries syndrome via IGF-1 mediated PI3K/Akt pathway.下调长链非编码 RNA HOTAIR 通过 IGF-1 介导的 PI3K/Akt 通路改善多囊卵巢综合征。
Gynecol Endocrinol. 2023 Jun 19;39(1):2227280. doi: 10.1080/09513590.2023.2227280.
6
LncRNA HCP5 promotes cell proliferation and inhibits apoptosis via miR-27a-3p/IGF-1 axis in human granulosa-like tumor cell line KGN.长链非编码 RNA HCP5 通过 miR-27a-3p/IGF-1 轴促进人颗粒细胞样肿瘤细胞系 KGN 的增殖并抑制凋亡。
Mol Cell Endocrinol. 2020 Mar 1;503:110697. doi: 10.1016/j.mce.2019.110697. Epub 2019 Dec 28.
7
MicroRNA-21 inhibits ovarian granulosa cell proliferation by targeting SNHG7 in premature ovarian failure with polycystic ovary syndrome.微小 RNA-21 通过靶向多囊卵巢综合征性卵巢早衰中的 SNHG7 抑制卵巢颗粒细胞增殖。
J Reprod Immunol. 2021 Aug;146:103328. doi: 10.1016/j.jri.2021.103328. Epub 2021 May 5.
8
LncRNA SNHG12 promotes cell proliferation and inhibits apoptosis of granulosa cells in polycystic ovarian syndrome by sponging miR-129 and miR-125b.LncRNA SNHG12 通过海绵吸附 miR-129 和 miR-125b 促进多囊卵巢综合征颗粒细胞增殖并抑制细胞凋亡。
J Ovarian Res. 2024 Apr 2;17(1):72. doi: 10.1186/s13048-024-01392-6.
9
The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B.miR-324-3p 通过靶向 WNT2B 在多囊卵巢综合征(PCOS)中的作用。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3286-3293. doi: 10.26355/eurrev_201806_15147.
10
Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome.抑制 microRNA-19b 通过靶向 IGF-1 促进多囊卵巢综合征中的卵巢颗粒细胞增殖。
Mol Med Rep. 2018 Apr;17(4):4889-4898. doi: 10.3892/mmr.2018.8463. Epub 2018 Jan 22.

引用本文的文献

1
The Role of Ovarian Granulosa Cells Related-ncRNAs in Ovarian Dysfunctions: Mechanism Research and Clinical Exploration.卵巢颗粒细胞相关非编码RNA在卵巢功能障碍中的作用:机制研究与临床探索
Reprod Sci. 2025 Apr 2. doi: 10.1007/s43032-025-01854-2.
2
Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery.非编码 RNA 在 2 型糖尿病中的新兴作用:从机制到药物发现。
Biomolecules. 2024 Oct 27;14(11):1364. doi: 10.3390/biom14111364.
3
Porcine granulosa cell transcriptomic analyses reveal the differential regulation of lncRNAs and mRNAs in response to all-trans retinoic acid in vitro.

本文引用的文献

1
Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing.通过深度测序分析来曲唑诱导的多囊卵巢综合征大鼠模型卵巢中mRNA和长链非编码RNA的表达谱。
Gene. 2018 May 30;657:19-29. doi: 10.1016/j.gene.2018.03.002. Epub 2018 Mar 2.
2
The effect of lncRNA HOTAIR on chemoresistance of ovarian cancer through regulation of HOXA7.长链非编码 RNA HOTAIR 通过调节 HOXA7 对卵巢癌化疗耐药性的影响。
Biol Chem. 2018 Apr 25;399(5):485-497. doi: 10.1515/hsz-2017-0274.
3
Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells.
猪颗粒细胞转录组分析揭示了体外全反式维甲酸刺激下lncRNAs和mRNAs的差异调控。
Anim Biosci. 2025 Feb;38(2):267-277. doi: 10.5713/ab.24.0363. Epub 2024 Aug 26.
4
Whispers of the polycystic ovary syndrome theater: Directing role of long noncoding RNAs.多囊卵巢综合征舞台的低语:长链非编码RNA的主导作用
Noncoding RNA Res. 2024 May 14;9(4):1023-1032. doi: 10.1016/j.ncrna.2024.05.003. eCollection 2024 Dec.
5
Granulosa Cells-Related MicroRNAs in Ovarian Diseases: Mechanism, Facts and Perspectives.卵巢疾病中与颗粒细胞相关的微小RNA:机制、现状与展望
Reprod Sci. 2024 Dec;31(12):3635-3650. doi: 10.1007/s43032-024-01523-w. Epub 2024 Apr 9.
6
Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS).多囊卵巢综合征(PCOS)中竞争性内源性RNA网络的生物标志物潜力
Noncoding RNA Res. 2024 Jan 17;9(2):624-640. doi: 10.1016/j.ncrna.2024.01.002. eCollection 2024 Jun.
7
LncRNA HOTAIR regulates autophagy and proliferation mechanisms in premature ovarian insufficiency through the miR-148b-3p/ATG14 axis.长链非编码RNA HOTAIR通过miR-148b-3p/ATG14轴调控卵巢早衰中的自噬和增殖机制。
Cell Death Discov. 2024 Jan 24;10(1):44. doi: 10.1038/s41420-024-01811-z.
8
The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review.miRNA、lncRNA 和环状 RNA 在多囊卵巢综合征发病机制中的作用:文献综述。
Int J Mol Sci. 2024 Jan 11;25(2):903. doi: 10.3390/ijms25020903.
9
The functional role of lncRNAs as ceRNAs in both ovarian processes and associated diseases.长链非编码RNA作为竞争性内源RNA在卵巢生理过程及相关疾病中的功能作用。
Noncoding RNA Res. 2023 Nov 18;9(1):165-177. doi: 10.1016/j.ncrna.2023.11.008. eCollection 2024 Mar.
10
Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors.胃肠道间质瘤对伊马替尼继发性耐药机制的研究进展
Front Oncol. 2022 Sep 6;12:933248. doi: 10.3389/fonc.2022.933248. eCollection 2022.
肿瘤相关巨噬细胞上调 IGF1 促进上皮性卵巢癌细胞的增殖和迁移。
Oncol Rep. 2018 Feb;39(2):818-826. doi: 10.3892/or.2017.6148. Epub 2017 Dec 11.
4
Long Noncoding RNAs: Potential Regulators Involved in the Pathogenesis of Polycystic Ovary Syndrome.长链非编码RNA:参与多囊卵巢综合征发病机制的潜在调节因子
Endocrinology. 2017 Nov 1;158(11):3890-3899. doi: 10.1210/en.2017-00605.
5
Insulin and the polycystic ovary syndrome.胰岛素与多囊卵巢综合征。
Diabetes Res Clin Pract. 2017 Aug;130:163-170. doi: 10.1016/j.diabres.2017.06.011. Epub 2017 Jun 12.
6
Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer.利用肿瘤特异性肽进行治疗靶向抑制卵巢癌和乳腺癌中的长非编码 RNA HOTAIR 活性。
Sci Rep. 2017 Apr 18;7(1):894. doi: 10.1038/s41598-017-00966-3.
7
Polycystic ovary syndrome: analysis of the global research architecture using density equalizing mapping.多囊卵巢综合征:使用密度均衡映射对全球研究架构的分析
Reprod Biomed Online. 2017 Jun;34(6):627-638. doi: 10.1016/j.rbmo.2017.03.010. Epub 2017 Mar 21.
8
Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.长链非编码RNA HOTAIR调控从乳腺癌细胞中富集的癌干细胞样细胞(CSC)亚群的增殖、自我更新能力、肿瘤形成及迁移。
PLoS One. 2017 Jan 25;12(1):e0170860. doi: 10.1371/journal.pone.0170860. eCollection 2017.
9
Effects of Quercetin on Adiponectin-Mediated Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Double-Blind Clinical Trial.槲皮素对多囊卵巢综合征中脂联素介导的胰岛素敏感性的影响:一项随机安慰剂对照双盲临床试验
Horm Metab Res. 2017 Feb;49(2):115-121. doi: 10.1055/s-0042-118705. Epub 2016 Nov 7.
10
HOTAIR rs920778 polymorphism is associated with ovarian cancer susceptibility and poor prognosis in a Chinese population.HOTAIR基因rs920778多态性与中国人群卵巢癌易感性及不良预后相关。
Future Oncol. 2017 Feb;13(4):347-355. doi: 10.2217/fon-2016-0290. Epub 2016 Oct 3.